Ind-Swift Laboratories Arbitration Award Nil Impact

Ind-Swift Laboratories received a final arbitration award on 7th April 2026, rejecting all claims and counterclaims with no financial impact.
The company responded to BSE's surveillance query on volume spurt, attributing it to market conditions and the arbitration disclosure.
Ind-Swift affirmed its compliance with SEBI Listing Regulations, including timely disclosure of all material information.